Survival and Mortality in Hospitalized Children with COVID-19: A Referral Center Experience in Yazd, Iran
Table 2
Laboratory findings of children with COVID-19 in Shahid Sadoughi Hospital in Yazd.
Variables
Total (n = 183)
Survived (n = 159)
Deceased (n = 24)
Cramer’s V/Eta
value
PCR outcomes
Positive
128.0 (70.0)
113.0 (71.0)
15.0 (62.5)
0.06
0.39
Negative
55.0 (30.0)
46.0 (29.0)
9.0 (37.5)
WBC (×103/μL)
<5000
104.0 (60.8)
89.0 (60.0)
15.0 (65.2)
0.09
0.47
5000–15000
37.0 (21.6)
31.0 (21.0)
6.0 (26.0)
>15000
30.0 (17.5)
28.0 (19.0)
2.0 (8.8)
PLT (×103/μL)
<15000
113.0 (67.0)
98.0 (67.6)
15.0 (62.5)
0.05
0.81
15000–45000
34.0 (20.0)
28.0 (19.3)
6.0 (25.0)
>45000
22.0 (13.0)
19.0 (13.1)
3.0 (12.5)
Lymphopenia
No
105.0 (71.0)
95.0 (73.5)
10.0 (52.5)
0.15
0.06
Yes
43.0 (29.0)
34.0 (26.5)
9.0 (47.5)
CRP
0
49.0 (33.0)
43.0 (33.5)
6.0 (33.3)
0.18
0.17
1+
32.0 (22.0)
26.0 (20.0)
6.0 (33.3)
2+
41.0 (28.0)
35.0 (27.0)
6.0 (33.3)
3+
25.0 (17.0)
25.0 (19.5)
0 (0.0)
BUN (mg/dL)
≤20
32.0 (31.7)
26.0 (31.3)
6.0 (33.3)
0.02
0.86
>20
69.0 (68.3)
57.0 (68.7)
12.0 (66.7)
CR (mg/dL)
≤1.5
129.0 (83.2)
112.0 (83.0)
17.0 (85.0)
0.02
0.82
>1.5
26.0 (16.8)
23.0 (17.0)
3.0 (15.0)
NA (mEq/L)
<135
95.0 (60.5)
84.0 (62.0)
11.0 (52.5)
0.08
0.62
135–145
58.0 (37.0)
49.0 (36.0)
9.0 (43.0)
>145
4.0 (2.5)
3.0 (2.0)
1.0 (4.5)
K (mEq/L)
<3.5
133.0 (88.0)
115.0 (87.8)
18.0 (90.0)
0.07
0.66
3.5–5.5
13.0 (8.7)
11.0 (8.5)
2.0 (10.0)
>5.5
5.0 (3.3)
5.0 (3.7)
0.0 (0.0)
CA (mg/dL)
<8.8
43.0 (49.5)
38.0 (54.3)
5.0 (29.5)
0.21
0.14
8.8–10.8
43.0 (49.5)
31.0 (44.3)
12.0 (70.5)
>10.8
1.0 (1.0)
1.0 (1.4)
0.0 (0.0)
MG (mEq/L)
>105
61.0 (97.0)
45.0 (95.7)
16.0 (100.0)
0.10
1.00
<105
2.0 (3.0)
2.0 (4.3)
0.0 (0.0)
P (mg/dL)
<3
42.0 (82.5)
33.0 (84.5)
9.0 (75.0)
0.14
0.61
3–6
7.0 (13.5)
5.0 (13.0)
2.0 (16.5)
>6
2.0 (4.0)
1.0 (2.5)
1.0 (8.5)
ALT (U/L)
8–35
65.0 (59.5)
56.0 (60.0)
9.0 (56.3)
0.03
0.76
>35
44.0 (40.5)
37.0 (40.0)
7.0 (43.8)
AST (U/L)
15–45
63.0 (57.3)
57.0 (60.5)
6.0 (37.5)
0.16
0.08
>45
47.0 (42.7)
37.0 (39.5)
10.0 (62.5)
LDH (U/L)
≤500
45.0 (47.5)
40.0 (48.0)
5.0 (42.0)
0.04
0.67
>500
50.0 (52.5)
43.0 (52.0)
7.0 (58.0)
Albumin (g/dL)
≥3.5
13.0 (56.5)
11.0 (61.0)
2.0 (40.0)
0.17
0.62
<3.5
10.0 (43.5)
7.0 (39.0)
3.0 (60.0)
ESR (mm/h)
≤30
49.0 (51.5)
42.0 (52.5)
7.0 (47.0)
0.04
0.67
>30
46.0 (48.5)
38.0 (47.5)
8.0 (53.0)
D-dimer
≤200
13.0 (48.0)
11.0 (48.0)
2.0 (50.0)
0.01
0.94
>200
14.0 (52.0)
12.0 (52.0)
2.0 (50.0)
CPK (U/L)
≤200
67.0 (87.0)
61.0 (89.7)
6.0 (66.7)
0.22
0.05
>200
10.0 (13.0)
7.0 (10.3)
3.0 (33.3)
PTT (s)
24–36
41.0 (74.5)
31.0 (70.5)
10.0 (91.0)
0.19
0.16
>36
14.0 (25.5)
13.0 (29.5)
1.0 (9.0)
PT (s)
11–12
14.0 (25.5)
12.0 (27.3)
2.0 (18.0)
0.08
0.54
>12
41.0 (74.5)
32.0 (72.7)
9.0 (82.0)
INR
<1.5
19.0 (86.5)
14.0 (82.5)
5.0 (100)
0.21
0.31
>1.5
3.0 (13.5)
3.0 (17.5)
0.0 (0.0)
BS (mg/dL)
<60
2.0 (2.0)
2.0 (2.5)
0.0 (0.0)
0.06
0.83
60–200
90.0 (92.0)
77.0 (91.5)
13.0 (93.0)
>200
6.0 (6.0)
5.0 (6.0)
1.0 (7.0)
UARBC
≤4
27.0 (93.0)
21.0 (95.5)
6.0 (86.7)
0.16
0.38
>4
2.0 (7.0)
1.0 (4.5)
1.0 (14.3)
UAWBC
Normal
29.0 (88.0)
21.0 (84.0)
8.0 (100)
0.21
0.23
Abnormal
4.0 (12.0)
4.0 (16.0)
0.0 (0.0)
Frequency (%) was used for describing the categorical variables. The Cramer’s V, chi-square, and Fisher exact tests were used to measure the association between categorical variables and status. The first-time measured values of all laboratory findings are summarized in categories. CR was divided into normal/abnormal categories based on age groups.
